INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 46h ago
House PTR6h ago
SEC 13F6h ago
Robinhood Chain6h ago

Most active filers · 30d

  1. 01Kurtz George0B / 217S · 10 late217 trades$54.77M
  2. 02SPSaba Capital Management, L.P.55B / 21S · 3 late76 trades$25.87M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05CFCheng Chi Fung0B / 42S42 trades$15.33M
  6. 06RARothblatt Martine A0B / 33S33 trades$5.50M
  7. 07RJRubinstein Julie0B / 32S32 trades$5.55M
  8. 08LBLeach Bryan0B / 30S30 trades$7.97M
  9. 09AOAtay Oguzhan0B / 30S30 trades$7.55M
  10. 10JDJenkins William D Jr0B / 30S30 trades$13.38M

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. BUYMTDRMatador Resources CoNov 5 – Nov 98 insiders$625K
  3. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  4. SELL
SYMSymbotic Inc.Oct 26 – Nov 2
7 insiders$1.98M
  • BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  • SELLIBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
  • SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
  • BUYBBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K

    • Form 4 transactions

    18,921 records
    Side
    allbuysell
    Score
    any≥ 30≥ 50≥ 70
    Sort
    Newest disclosedNewest executedInsider ScoreValue
    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    3
    CM
    Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner
    TEAMAtlassian Corp
    Open-market sale · 10b5-1 plan
    		SELL$39K
    280 sh
    		Jan 28, 2026Jan 29, 2026
    Page 345 of 474
    ← PrevNext →
    traded Jan 28, 2026
    +1d
    SEC Form 4

    Evidence

    3
    RR
    Remer Eric RichardDirector, Chief Executive Officer
    EVCMEverCommerce Inc.
    Open-market sale · 10b5-1 plan
    		SELL$36K
    3,090 sh
    		Jan 29, 2026Jan 29, 2026
    traded Jan 29, 2026
    		+0dSEC Form 4

    Evidence

    3
    Farquhar ScottDirector, 10% Owner
    TEAMAtlassian Corp
    Open-market sale · 10b5-1 plan
    		SELL$39K
    281 sh
    		Jan 28, 2026Jan 29, 2026
    traded Jan 28, 2026
    		+1dSEC Form 4

    Evidence

    2
    BR
    Bentley Sheldon Richard10% Owner, Founder
    CSAICLOUDASTRUCTURE, INC.
    Open-market sale · 10b5-1 plan
    		SELL$22K
    25.0K sh
    		Jan 27, 2026Jan 29, 2026
    traded Jan 27, 2026
    		+2dSEC Form 4

    Evidence

    1
    GR
    Gallagher John RChief Operating Officer
    TRUPTRUPANION, INC.
    Open-market sale · 10b5-1 plan
    		SELL$14K
    430 sh
    		Jan 28, 2026Jan 29, 2026
    traded Jan 28, 2026
    		+1dSEC Form 4

    Evidence

    66
    NE
    Nelson Jeffrey EdwardChief Operating Officer
    MISTMilestone Pharmaceuticals Inc.
    Open-market sale
    		SELL$135K
    58.0K sh
    		Dec 15, 2025Jan 28, 2026
    traded Dec 15, 2025
    		+44dSEC Form 4

    Evidence

    62
    ML
    Muller LorenzChief Commercial Officer
    MISTMilestone Pharmaceuticals Inc.
    Open-market sale
    		SELL$124K
    53.6K sh
    		Dec 15, 2025Jan 28, 2026
    traded Dec 15, 2025
    		+44dSEC Form 4

    Evidence

    62
    BD
    Bharucha DavidChief Medical Officer
    MISTMilestone Pharmaceuticals Inc.
    Open-market sale
    		SELL$135K
    58.0K sh
    		Dec 15, 2025Jan 28, 2026
    traded Dec 15, 2025
    		+44dSEC Form 4

    Evidence

    62
    HA
    Hasija AmitCFO & EVP of Corp. Development
    MISTMilestone Pharmaceuticals Inc.
    Open-market sale
    		SELL$135K
    58.0K sh
    		Dec 15, 2025Jan 28, 2026
    traded Dec 15, 2025
    		+44dSEC Form 4

    Evidence

    38
    MB
    McBee BranninChief Development Officer
    CRWVCoreWeave, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$78K
    731 sh
    		Jan 26, 2026Jan 28, 2026
    traded Jan 26, 2026
    		+2dSEC Form 4

    Evidence

    38
    MB
    McBee BranninChief Development Officer
    CRWVCoreWeave, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$132K
    1,239 sh
    		Jan 26, 2026Jan 28, 2026
    traded Jan 26, 2026
    		+2dSEC Form 4

    Evidence

    38
    MB
    McBee BranninChief Development Officer
    CRWVCoreWeave, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$78K
    730 sh
    		Jan 26, 2026Jan 28, 2026
    traded Jan 26, 2026
    		+2dSEC Form 4

    Evidence

    38
    MB
    McBee BranninChief Development Officer
    CRWVCoreWeave, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$132K
    1,238 sh
    		Jan 26, 2026Jan 28, 2026
    traded Jan 26, 2026
    		+2dSEC Form 4

    Evidence

    37
    MB
    McBee BranninChief Development Officer
    CRWVCoreWeave, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$631K
    6,209 sh
    		Jan 26, 2026Jan 28, 2026
    traded Jan 26, 2026
    		+2dSEC Form 4

    Evidence

    37
    MB
    McBee BranninChief Development Officer
    CRWVCoreWeave, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$691K
    7,007 sh
    		Jan 26, 2026Jan 28, 2026
    traded Jan 26, 2026
    		+2dSEC Form 4

    Evidence

    37
    MB
    McBee BranninChief Development Officer
    CRWVCoreWeave, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$631K
    6,209 sh
    		Jan 26, 2026Jan 28, 2026
    traded Jan 26, 2026
    		+2dSEC Form 4

    Evidence

    37
    MB
    McBee BranninChief Development Officer
    CRWVCoreWeave, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$691K
    7,007 sh
    		Jan 26, 2026Jan 28, 2026
    traded Jan 26, 2026
    		+2dSEC Form 4

    Evidence

    36
    MB
    McBee BranninChief Development Officer
    CRWVCoreWeave, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$2.60M
    25.5K sh
    		Jan 26, 2026Jan 28, 2026
    traded Jan 26, 2026
    		+2dSEC Form 4

    Evidence

    36
    HA
    Hasija AmitCFO & EVP of Corp. Development
    MISTMilestone Pharmaceuticals Inc.
    Open-market sale
    		SELL$24K
    12.2K sh
    		Jan 26, 2026Jan 28, 2026
    traded Jan 26, 2026
    		+2dSEC Form 4

    Evidence

    36
    BD
    Bharucha DavidChief Medical Officer
    MISTMilestone Pharmaceuticals Inc.
    Open-market sale
    		SELL$24K
    12.2K sh
    		Jan 26, 2026Jan 28, 2026
    traded Jan 26, 2026
    		+2dSEC Form 4

    Evidence

    36
    ML
    Muller LorenzChief Commercial Officer
    MISTMilestone Pharmaceuticals Inc.
    Open-market sale
    		SELL$22K
    11.2K sh
    		Jan 26, 2026Jan 28, 2026
    traded Jan 26, 2026
    		+2dSEC Form 4

    Evidence

    36
    MB
    McBee BranninChief Development Officer
    CRWVCoreWeave, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$2.84M
    28.8K sh
    		Jan 26, 2026Jan 28, 2026
    traded Jan 26, 2026
    		+2dSEC Form 4

    Evidence

    36
    NE
    Nelson Jeffrey EdwardChief Operating Officer
    MISTMilestone Pharmaceuticals Inc.
    Open-market sale
    		SELL$24K
    12.2K sh
    		Jan 26, 2026Jan 28, 2026
    traded Jan 26, 2026
    		+2dSEC Form 4

    Evidence

    35
    SC
    Spencer CourtneyChief Experience Officer
    LOBLive Oak Bancshares, Inc.
    Open-market sale
    		SELL$378K
    9,700 sh
    		Jan 26, 2026Jan 28, 2026
    traded Jan 26, 2026
    		+2dSEC Form 4

    Evidence

    35
    MB
    McBee BranninChief Development Officer
    CRWVCoreWeave, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$23K
    218 sh
    		Jan 26, 2026Jan 28, 2026
    traded Jan 26, 2026
    		+2dSEC Form 4

    Evidence

    35
    MB
    McBee BranninChief Development Officer
    CRWVCoreWeave, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$7,776
    73 sh
    		Jan 26, 2026Jan 28, 2026
    traded Jan 26, 2026
    		+2dSEC Form 4

    Evidence

    35
    MB
    McBee BranninChief Development Officer
    CRWVCoreWeave, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$7,776
    73 sh
    		Jan 26, 2026Jan 28, 2026
    traded Jan 26, 2026
    		+2dSEC Form 4

    Evidence

    35
    MB
    McBee BranninChief Development Officer
    CRWVCoreWeave, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$9,179
    85 sh
    		Jan 26, 2026Jan 28, 2026
    traded Jan 26, 2026
    		+2dSEC Form 4

    Evidence

    35
    MB
    McBee BranninChief Development Officer
    CRWVCoreWeave, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$28K
    255 sh
    		Jan 26, 2026Jan 28, 2026
    traded Jan 26, 2026
    		+2dSEC Form 4

    Evidence

    35
    MB
    McBee BranninChief Development Officer
    CRWVCoreWeave, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$27K
    254 sh
    		Jan 26, 2026Jan 28, 2026
    traded Jan 26, 2026
    		+2dSEC Form 4

    Evidence

    35
    MB
    McBee BranninChief Development Officer
    CRWVCoreWeave, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$44K
    413 sh
    		Jan 26, 2026Jan 28, 2026
    traded Jan 26, 2026
    		+2dSEC Form 4

    Evidence

    35
    MB
    McBee BranninChief Development Officer
    CRWVCoreWeave, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$26K
    243 sh
    		Jan 26, 2026Jan 28, 2026
    traded Jan 26, 2026
    		+2dSEC Form 4

    Evidence

    34
    MB
    McBee BranninChief Development Officer
    CRWVCoreWeave, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$210K
    2,070 sh
    		Jan 26, 2026Jan 28, 2026
    traded Jan 26, 2026
    		+2dSEC Form 4

    Evidence

    34
    MB
    McBee BranninChief Development Officer
    CRWVCoreWeave, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$62K
    589 sh
    		Jan 26, 2026Jan 28, 2026
    traded Jan 26, 2026
    		+2dSEC Form 4

    Evidence

    34
    MB
    McBee BranninChief Development Officer
    CRWVCoreWeave, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$75K
    763 sh
    		Jan 26, 2026Jan 28, 2026
    traded Jan 26, 2026
    		+2dSEC Form 4

    Evidence

    34
    MB
    McBee BranninChief Development Officer
    CRWVCoreWeave, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$167K
    1,602 sh
    		Jan 26, 2026Jan 28, 2026
    traded Jan 26, 2026
    		+2dSEC Form 4

    Evidence

    34
    MB
    McBee BranninChief Development Officer
    CRWVCoreWeave, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$56K
    534 sh
    		Jan 26, 2026Jan 28, 2026
    traded Jan 26, 2026
    		+2dSEC Form 4

    Evidence

    34
    MB
    McBee BranninChief Development Officer
    CRWVCoreWeave, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$230K
    2,336 sh
    		Jan 26, 2026Jan 28, 2026
    traded Jan 26, 2026
    		+2dSEC Form 4

    Evidence

    34
    BM
    Benkowitz MichaelPRESIDENT AND COO
    UTHRUNITED THERAPEUTICS Corp
    Open-market sale · 10b5-1 plan
    		SELL$736K
    1,573 sh
    		Jan 20, 2026Jan 28, 2026
    traded Jan 20, 2026
    		+8dSEC Form 4

    Evidence

    34
    MB
    McBee BranninChief Development Officer
    CRWVCoreWeave, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$72K
    709 sh
    		Jan 26, 2026Jan 28, 2026
    traded Jan 26, 2026
    		+2dSEC Form 4

    Evidence